Jiehui Di

795 total citations
37 papers, 647 citations indexed

About

Jiehui Di is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiehui Di has authored 37 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jiehui Di's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Cancer-related Molecular Pathways (6 papers) and Ubiquitin and proteasome pathways (5 papers). Jiehui Di is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Cancer-related Molecular Pathways (6 papers) and Ubiquitin and proteasome pathways (5 papers). Jiehui Di collaborates with scholars based in China, United States and Singapore. Jiehui Di's co-authors include Junnian Zheng, Junnian Zheng, Dong‐Sheng Pei, Jin Bai, Huấn Cao, Juanjuan Tang, Baofu Zhang, Hui Tian, Huizhong Li and Zheng Lu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Jiehui Di

36 papers receiving 645 citations

Peers

Countries citing papers authored by Jiehui Di

Since Specialization

Citations

This map shows the geographic impact of Jiehui Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiehui Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiehui Di more than expected).

Fields of papers citing papers by Jiehui Di

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiehui Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiehui Di. The network helps show where Jiehui Di may publish in the future.

Co-authorship network of co-authors of Jiehui Di

This figure shows the co-authorship network connecting the top 25 collaborators of Jiehui Di. A scholar is included among the top collaborators of Jiehui Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiehui Di. Jiehui Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel near-infrared iridium(III) complex-based multimodal probe for multi-signal detecting of peroxynitrite in vitro and in vivo 2025 ·Sensors and Actuators B Chemical ·Chaolong Liu, Wenyu Wang, (unknown), Jiehui Di, (unknown)	2
2	Novel cyclometalated iridium(III) complex-based two-photon probe for visualizing mitochondrial nitroreductase and assessing treatment responses in sepsis-induced lung injury 2025 ·Analytica Chimica Acta ·Chaolong Liu, Peng Du, Yuan Lü, (unknown), Jiehui Di, Yong Sun	2
3	Nucleolin malonylation as a nuclear-cytosol signal exchange mechanism to drive cell proliferation in Hepatocarcinoma by enhancing AKT translation 2024 ·Journal of Biological Chemistry ·Liang Sun, (unknown), Tao Liu, Qiong Zhao, (unknown), Zhongjun Zhao, Yuting Qian, Hao Cui, (unknown), (unknown), Yang Tian, Yang Sun, Bao Zhu, Jiehui Di, Guanghou Shui, Lianjun Zhang, Junnian Zheng, (unknown), Yong Liu	4
4	A novel nonsense mutation of PNLDC1 associated with male infertility due to oligo-astheno-teratozoospermia in a consanguineous Chinese family 2023 ·QJM ·Fang Qiu, Xin Bi, Wei Hong, (unknown), Jiehui Di, Yi Liu, (unknown), (unknown)	1
5	Role of plectin and its interacting molecules in cancer 2023 ·Medical Oncology ·Keyu Gao, Zhimin Gao, (unknown), Hailong Li, Jiehui Di	6
6	The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma 2022 ·Medical Oncology ·Hui Huang, Tao Chen, Fei Li, Dan Jin, Chuan Li, (unknown), Xuyang Liu, Dongmiao Wang, Jiehui Di	2
7	A p53/CPEB2 negative feedback loop regulates renal cancer cell proliferation and migration 2021 ·Journal of genetics and genomics ·Jiehui Di, Guang Zhao, (unknown), (unknown), Zhongjun Zhao, Bao Zhu, Yanping Zhang, Junnian Zheng, Yong Liu, Ying Hu	8
8	CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma 2021 ·Frontiers in Cell and Developmental Biology ·Jiehui Di, Hui Wang, Zhongjun Zhao, Guang Zhao, Xiaobing Qin, Zhengxiang Han, Yong Liu	5
9	ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway. 2019 ·PubMed ·(unknown), (unknown), Jiehui Di, Meifeng Yang, (unknown)	7
10	Ischemic preconditioning protects the brain against injury via inhibiting CaMKII–nNOS signaling pathway 2016 ·Brain Research ·Mei Wang, Dashi Qi, Cui Zhou, Dong Han, Peipei Li, (unknown), Xiaoyan Zhou, (unknown), Jiehui Di, (unknown), Hongmin Yu, Yuanjian Song, Guangyi Zhang	15
11	Rap2B GTPase: structure, functions, and regulation 2016 ·Tumor Biology ·(unknown), Jiehui Di, Zheng Lu, Keyu Gao, Junnian Zheng	10
12	p53-mediated autophagic regulation: A prospective strategy for cancer therapy 2015 ·Cancer Letters ·Juanjuan Tang, Jiehui Di, Huấn Cao, Jin Bai, Junnian Zheng	84
13	p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading 2015 ·Journal of Cancer Research and Clinical Oncology ·Jiehui Di, Hui Huang, (unknown), (unknown), Juanjuan Tang, Qian Cheng, Zheng Lu, Yanping Zhang, Junnian Zheng	11
14	CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation 2014 ·Cell Death and Differentiation ·(unknown), Hilary V. Clegg, Patrick L. Leslie, Jiehui Di, Laura A. Tollini, Yizhou He, Tae Hee Kim, (unknown), Lee M. Graves, Junnian Zheng, Yingao Zhang	88
15	IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation 2012 ·Tumor Biology ·Feifei Chen, Jian Song, Jiehui Di, Qing Zhang, Hui Tian, Junnian Zheng	10
16	Critical Role of Lysine 123 in the Ubiquitin-Mediated Degradation of MDA-7/IL-24 2012 ·Journal of Interferon & Cytokine Research ·Hui Tian, Liantao Li, Baofu Zhang, Jiehui Di, Feifei Chen, Huizhong Li, Junjie Liu, Dong‐Sheng Pei, (unknown)	3
17	Potent Antitumor Effect Elicited by RGD- mda-7 , an mda-7 /IL-24 Mutant, via Targeting the Integrin Receptor of Tumor Cells 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Baofu Zhang, Jun-Jie Liu, Dong‐Sheng Pei, Zhi‐Xia Yang, Jiehui Di, Feifei Chen, Huizhong Li, Wei Xu, Yong-Ping Wu, (unknown)	14
18	Reactivation of p53 by Inhibiting Mdm2 E3 Ligase: A Novel Antitumor Approach 2011 ·Current Cancer Drug Targets ·Jiehui Di, (unknown), Jun Zheng	18
19	A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression 2010 ·Tumor Biology ·Hui Tian, (unknown), Wang Li, Feifei Chen, Jiehui Di, Baofu Zhang, Dong‐Sheng Pei, Ping Ma, Junnian Zheng	24
20	Oncolytic-adenovirus-expressed RNA interference for cancer therapy 2010 ·Expert Opinion on Biological Therapy ·Dong‐Sheng Pei, Jiehui Di, Feifei Chen, Junnian Zheng	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact